NF-κB determines localization and features of cell death in epidermis

Journal of Clinical Investigation

Volumn 105, Issue 3, 2000, Pages 253-260

  Seitz, Cornelia S ^a,b   Freiberg, Rachel A ^a,b   Hinata, Kaede ^a,b   Khavari, Paul A ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL FACTOR; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LORICRIN; TUMOR NECROSIS FACTOR ALPHA; BIRC2 PROTEIN, MOUSE; BIRC3 PROTEIN, MOUSE; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROTECTION; EPIDERMIS; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; TRANSGENIC MOUSE; ANIMAL; APOPTOSIS; GENE EXPRESSION REGULATION; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CELL DEATH; EPIDERMIS; GENE EXPRESSION REGULATION; INHIBITOR OF APOPTOSIS PROTEINS; MICE; NF-KAPPA B; PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; TNF RECEPTOR-ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033621589     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7630     Document Type: Article

References (59)

1. Tamada, Y., et al. 1994. Identification of programmed cell death in normal human skin tissues by using specific labelling of fragmented DNA. Br. J. Dermatol. 131:521-524.
2. Polakowska, R., Piacentini, M., Bartlett, R., Goldsmith, L., and Haake, A.R. 1994. Apoptosis in human skin development: morphogenesis, periderm, and stem cells. Dev. Dyn. 199:176-188.
3. Vaux, D.L., and Korsmeyer, S.J. 1999. Cell death in development. Cell. 96:245-254.
4. Haake, A.R., and Polakowska, R.R. 1993. Cell death by apoptosis in epidermal biology. J. Invest. Dermatol. 101:107-112.
5. Hill, L.L., et al. 1999. Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science. 285:898-900.
6. Baichwal, V., and Baeuerle, P.A. 1997. Activate NF-kappa B or die? Curr. Biol. 7:R94-R96.
7. Beg, A., Sha, W., Bronson, R.T., Ghosh, S., and Baltimore, D. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature. 376:167-170.
8. Liu, Z.G., Hsu, H., Goeddel, D.V., and Karin, M. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell. 87:565-576.
9. Wang, C.Y., Mayo, M.W., and Baldwin, A.S., Jr. 1996. TNF- and cancer therapy-induced apoptosis, potentiation by inhibition of NF-kappaB. Science. 274:784-787.
10. Van Antwerp, D.J., Martin, S.J., Kafri, T., Green, D.R., and Verma, I.M. 1996. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science. 274:787-789.
11. Wang, C.Y., Mayo, M.W., Korneluk, R.G., Goeddel, D.V., and Baldwin, A.S., Jr. 1998. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 281:1680-1683.
12. Wu, M.X., Ao, Z., Prasad, K.V., Wu, R., and Schlossman, S.F. 1998. IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science. 281:998-1001.
13. Deveraux, Q.L., Takahashi, R., Salvesen, G.S., and Reed, J.C. 1997. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 388:300-304.
14. Stehlik, C., et al. 1998. Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J. Exp. Med. 188:211-216.
15. Hettmann, T., DiDonato, J., Karin, M., and Leiden, J.M. 1999. An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis. J. Exp. Med. 189:145-158.
16. Dumont, A., et al. 1999. Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB. Oncogene. 18:747-757.
17. Schneider, A., et al. 1999. NF-kB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5:554-559.
18. Reuther, J.Y., Reuther, G., Cortez, D., Pendergast, A., and Baldwin, A.S., Jr. 1998. A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation. Genes Dev. 12:968-981.
19. Nakshatri, H., Bhat-Nakshatri, P., Martin, D.A., Goulet, R.J., Jr., and Sledge, G.W., Jr. 1997. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol. 17:3629-3639.
20. Wang, C.-Y., Cusack, J.C., Liu, R., and Baldwin, A.S. 1999. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kB. Nat. Med. 5:412-417.
21. Seitz, C.S., Lin, Q., Deng, H., and Khavari, P.A. 1998. Alterations in NF-kB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kB. Proc. Natl. Acad. Sci. USA. 95:2307-2312.
22. Takeda, K., et al. 1999. Limb and skin abnormalities in mice lacking IKKalpha. Science. 284:313-316.
23. Hu, Y., et al. 1999. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science. 284:316-320.
24. Li, Q., et al. 1999. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13:1322-1328.
25. Rheinwald, J.G., and Green, H. 1975. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell. 6:331-343.
26. Blank, V., Kourilsky, P., and Israel, A. 1991. Cytoplasmic retention, DNA binding and processing of the NF-kappa B p50 precursor are controlled by a small region in its C-terminus. EMBO J. 10:4159-4167.
27. Nolan, G.P., Ghosh, S., Liou, H., Tempst, P., and Baltimore, D. 1991. DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide. Cell. 64:961-969.
28. Logeat, F., et al. 1991. Inhibition of transcription factors belonging to the rel/NF-kappa B family by a transdominant negative mutant. EMBO J. 10:1827-1832.
29. Kinsella, T.M., and Nolan, G.P. 1996. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7:1405-1413.
30. Deng, H., Choate, K.A., Lin, Q., and Khavari, P.A. 1998. High efficiency gene transfer and pharmacologic selection of genetically engineered human keratinocytes. Biotechniques. 25:274-280.
31. Choate, K.A., Kinsella, T.M., Williams, M.L., Nolan, G.P., and Khavari, P.A. 1996. Transglutaminase 1 delivery to lamellar ichthyosis keratinocytes. Hum. Gene Ther. 7:2247-2253.
32. Zong, W.X., Bash, J., and Gelinas, C. 1998. Rel blocks both anti-Fas- and TNF alpha-induced apoptosis and an intact Rel transactivation domain is essential for this effect. Cell Death Differ. 5:963-972.
33. Viard, I., et al. 1998. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 282:490-493.
34. Sayama, K., Yonehara, S., Watanabe, Y., and Miki, Y. 1994. Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes. J. Invest. Dermatol. 103:330-334.
35. Freiberg, R.A., et al. 1996. Specific triggering of the Fas signal transduction pathway in normal human keratinocytes. J Biol. Chem. 271:31666-31669.
36. Aragane, Y., et al. 1998. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J. Cell Biol. 140:171-182.
37. Hsu, H., Shu, H., Pan, M., and Goeddel, D.V. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNFR1 signal transduction pathways. Cell. 84:299-308.
38. Haake, A.R., and Holbrook, K. 1999. The structure and development of skin. In Dermatology in general medicine. I Freeberg et al., editors. McGraw-Hill. New York, NY. 70-114.
39. Schmidt-Ullrich, R., et al. 1996. NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity. Development. 122:2117-2128.
40. Haake, A.R., and Cooklis, M. 1997. Incomplete differentiation of fetal keratinocytes in the skin equivalent leads to the default pathway of apoptosis. Exp. Cell Res. 231:83-95.
41. Mehrel, T., et al. 1990. Identification of a major keratinocyte cell envelope protein, loricrin. Cell. 61:1103-1112.
42. Deveraux, Q.L., and Reed, J.C. 1999. IAP family proteins: suppressors of apoptosis. Genes Dev. 13:239-252.
43. Deveraux, Q.L., Takahashi, R., Salvesen, G.S., and Reed, J.C. 1999. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 388:300-304.
44. Kothny-Wilkes, G., et al. 1998. Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand. J. Biol. Chem. 273:29247-29253.
45. van Hogerlinden, M., Rozell, B.L., Ahrlund-Richter, L., and Toftgard, R. 1999. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. Cancer Res. 59:3299-3303.
46. Uren, A.G., Pakusch, M., Hawkins, C.J., Puls, K.L., and Vaux, D.L. 1996. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc. Natl. Acad. Sci. USA. 93:4974-4978.
47. Chu, Z.L., et al., 1997. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc. Natl. Acad. Sci. USA. 94:10057-10062.
48. You, M., Ku, P.T., Hrdlickova, R., and Bose, H.R., Jr. 1997. ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the anti-apoptotic activity of the v-Rel oncoprotein. Mol. Cell. Biol. 17:7328-7341.
49. Grumont, R., Rourke, I., and Gerondakis, S. 1999. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13:400-411.
50. Zong, W.X., Edelstein, L.C., Chen, C., Bash, J., and Gelinas, C. 1999. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev. 13:382-387.
51. Ambrosini, G., Adida, C., and Altieri, D.C. 1997. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3:917-921.
52. Li, F., et al. 1998. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 396:580-584.
53. Pena, J.C., Fuchs, E., and Thompson, C.B. 1997. Bcl-x expression influences keratinocyte cell survival but not terminal differentiation. Cell Growth Differ. 8:619-629.
54. Pfeffer, K., et al. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 73:457-467.
55. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A., and Nagata, S. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 356:314-317.
56. Chaturvedi, V., et al. 1999. Apoptosis in proliferating, senescent, and immortalized keratinocytes. J. Biol. Chem. 274:23358-23367.
57. Gandarillas, A., Goldsmith, L.A., Gschmeissner, S., Leigh, I.M., and Watt, F.M. 1999. Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes. Exp. Dermatol. 8:71-79.
58. Mitra, R.S., et al. 1997. Apoptosis in keratinocytes is not dependent on induction of differentiation. Lab. Invest. 76:99-107.
59. Klement, J.F., et al. 1996. IkappaBalpha deficiency results in a sustained NF-kappaB response and sevre widespread dermatitis in mice. Mol. Cell. Biol. 16:2341-2349.